McKinley Capital Management’s Kite Pharma, Inc. KITE Stock Holding History

McKinley Capital Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-3,206	Closed	-$577K	–	388
2017 Q3	$577K	Sell	3,206 -1,315	-29%	-$183K	0.02%	263
2017 Q2	$469K	Sell	4,521 -73	-2%	-$5.96K	0.02%	261
2017 Q1	$361K	Sell	4,594 -263	-5%	-$16.3K	0.01%	291
2016 Q4	$218K	Sell	4,857 -871	-15%	-$42.7K	0.01%	358
2016 Q3	$320K	Buy	5,728 +16	+0.3%	+$891	0.01%	308
2016 Q2	$286K	Buy	5,712 +1,632	+40%	+$80.2K	0.01%	298
2016 Q1	$187K	Sell	4,080 -371	-8%	-$18K	0.01%	303
2015 Q4	$274K	Buy	4,451 +17	+0.4%	+$1.2K	0.01%	291
2015 Q3	$247K	Buy	+4,434	New	+$279K	0.01%	301

McKinley Capital Management's KITE Position: Q4 2017 in Review

McKinley Capital Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 3,206 shares — an estimated $577K sold.

McKinley Capital Management first reported a position in KITE in Q3 2015 and held it in 9 quarters. The position peaked at $577K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

McKinley Capital Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
McKinley Capital Management sold 3,206 Kite Pharma, Inc. shares in Q4 2017, an estimated $577K.
McKinley Capital Management first reported a position in Kite Pharma, Inc. in Q3 2015 and held it in 9 quarters.
McKinley Capital Management's Kite Pharma, Inc. position peaked at $577K in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on McKinley Capital Management's 13F filing for Q4 2017, filed 8 Feb 2018.